A28 Therapeutics

Targeted Oncolytic Peptides (TOPs) are the next generation of targeted cancer therapy. TOPs conjugates are less expensive, less complex and provide a more specific way of killing cancer cells without harming healthy cells all while recruiting the immune system to join the fight.